Alnylam Pharmaceuticals, Inc. v. Pfizer Inc., et al

  1. August 20, 2024

    Vax Patent Battles Heat Up As Attention On Pandemic Wanes

    It's been over four years since clinical trials began for COVID-19 vaccines, and while the shots have helped the pandemic recede, the lucrative technology has spurred numerous patent suits, many of which are still in the early stages. Here's a look at some of the key cases in the U.S.

  2. August 12, 2024

    Del. Judge Says Vaccine IP Claim Actually Mandates Vaccine

    Delaware's chief judge was baffled by Alnylam Pharmaceuticals' argument that the word "vaccine" in a patent it claims Pfizer and BioNTech have infringed doesn't actually require a vaccine, leading him to reject the trip down the rabbit hole presented by the company in exchange for "common sense."

  3. April 26, 2023

    Del. Judge Nixes Moderna Bid To Toss COVID Vax Patent Suit

    A Delaware federal judge on Wednesday swiftly rejected a request from pharmaceutical giant Moderna Inc. to toss patent infringement claims by Alnylam Pharmaceuticals Inc. over its COVID-19 vaccine, calling the request "premature."

  4. June 01, 2022

    Pfizer Attacks Rival's Claims Over Vaccine Patent In Del.

    Pfizer Inc. has ripped into patent infringement litigation brought by a Boston pharmaceutical company that claims to have discovered the mRNA delivery system used in COVID-19 vaccines, telling Delaware's top federal judge that its rival's efforts to make a vaccine had been remarkably "unsuccessful."

  5. May 23, 2022

    Moderna Wants Claims In COVID-19 Vax Patent Suit Tossed

    Moderna Inc. urged a Delaware federal court to nix several claims from an infringement suit claiming it used technology Alnylam Pharmaceuticals Inc. developed that ensures the mRNA in COVID-19 vaccines safely enters the body, arguing Monday that the claims belong in the U.S. Court of Federal Claims.

  6. March 17, 2022

    Rival Says Pfizer And Moderna Vaccines Rely On Its IP

    Alnylam Pharmaceuticals hit Moderna and Pfizer with separate patent infringement lawsuits Thursday, claiming they use technology it developed that ensures the mRNA in their COVID-19 vaccines safely enters the body.